1-1 of 1
Keywords: 2nd-line therapy
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Initial Experience with Temsirolimus in 2nd-, 3rd- and 4th-Line Therapy for Metastatic Renal Cell Cancer: Good Clinical Response

Available to Purchase
Subject Area:
Further Areas
Timur Hasan Kuru, Johannes Huber, Gencay Hatiboglu, Nina Wagener, Sascha Pahernik, Boris Hadaschik, Markus Hohenfellner
Journal: Urologia Internationalis
Urol Int (2011) 86 (3): 256–260.
https://doi.org/10.1159/000322545
Published Online: 25 January 2011
... Clinical Response Timur Hasan Kuru Johannes Huber Gencay Hatiboglu Nina Wagener Sascha Pahernik Boris Hadaschik Markus Hohenfellner Department of Urology, University of Heidelberg, Heidelberg, Germany Key Words Temsirolimus ? Metastatic renal cell carcinoma ? 2nd-line therapy ? Pneumonitis Abstract Purpose...
View article titled, Initial Experience with Temsirolimus in 2nd-, 3rd- and 4th-Line Therapy for Metastatic Renal Cell Cancer: Good Clinical Response
Open the PDF for Initial Experience with Temsirolimus in 2nd-, 3rd- and 4th-Line Therapy for Metastatic Renal Cell Cancer: Good Clinical Response in another window